Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HMGB1P15 is a **pseudogene** in humans that is homologous to the high mobility group box 1 (HMGB1) family but does not encode a functional protein[1]. Pseudogenes are genomic DNA sequences similar to regular genes but have accumulated mutations that prevent them from producing functional products[9]. While some pseudogenes have been shown to have regulatory effects or limited function, most—including HMGB1P15—are considered non-functional and do not act as drug or biomarker targets. HMGB1P15 is cataloged in gene databases as a pseudogene and is not implicated in any validated physiological or pathological processes[1]. **Summary:** HMGB1P15 is not a druggable or functional target but a non-functional DNA sequence categorized as a pseudogene, with no evidence of being a therapeutic target, molecular marker, or causative agent in disease[1][9]. If you are seeking information about the **functional high mobility group box 1 protein (HMGB1)**, which is actively researched as a damage-associated molecular pattern and has roles in inflammation and cancer, that is a different molecule than HMGB1P15.
None known for this pseudogene
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 1 pseudogene 15 (HMGB1P15).